Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DIRECT: Denosumab in Japanese Osteoporosis
NCT00680953Phase 3Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- May 2008
- Primary completion
- Jun 2012
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of denosumab in osteoporosis, sponsored by Daiichi Sankyo Co., Ltd.. Started May 2008; status: completed.
02
Drugs
denosumab
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00680953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00680953.